91 related articles for article (PubMed ID: 2539056)
1. [Comparison of the antitumor activity of newly developed platinum analogs in lung cancer using the colony assay].
Yonei T; Ohnoshi T; Hiraki S; Ueoka H; Yamashita H; Kozuka A; Moritaka T; Uji H; Kiura K; Mima Y
Gan To Kagaku Ryoho; 1989 Mar; 16(3 Pt 1):427-30. PubMed ID: 2539056
[No Abstract] [Full Text] [Related]
2. Antitumor activity of a new platinum compound (glycolate-o,o') diammineplatinum (II) (254-S), against non-small cell lung carcinoma grown in a human tumor clonogenic assay system.
Kanzawa F; Matsushima Y; Nakano H; Nakagawa K; Takahashi H; Sasaki Y; Saijo N
Anticancer Res; 1988; 8(3):323-7. PubMed ID: 2839098
[TBL] [Abstract][Full Text] [Related]
3. [Pharmacological approach to the platinum compounds].
Sasaki Y
Gan To Kagaku Ryoho; 1992 Apr; 19(4):456-62. PubMed ID: 1313667
[TBL] [Abstract][Full Text] [Related]
4. [Analysis of drug sensitivity by successive colony-forming assay].
Azuma A; Hino M; Hirosawa A; Shimabukuro Z; Aoyama A; Ootsuka M; Matsusaka M; Niitani H
Gan To Kagaku Ryoho; 1987 Mar; 14(3 Pt 2):815-20. PubMed ID: 3032106
[TBL] [Abstract][Full Text] [Related]
5. Prediction of the antitumor activity of new platinum analogs based on their ex vivo pharmacodynamics as determined by bioassay.
Sasaki Y; Shinkai T; Eguchi K; Tamura T; Ohe Y; Ohmori T; Saijo N
Cancer Chemother Pharmacol; 1991; 27(4):263-70. PubMed ID: 1847845
[TBL] [Abstract][Full Text] [Related]
6. [The prospect for cisplatin analogs from the experimental standpoint].
Tashiro T
Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 2-2):1358-65. PubMed ID: 2543305
[TBL] [Abstract][Full Text] [Related]
7. Effectiveness of cis-platin and carboplatin in the chemotherapy of squamous cell carcinoma grown as multicellular spheroids.
Schwachöfer JH; Crooijmans RP; Hoogenhout J; Kal HB; Theeuwes AG
Anticancer Res; 1990; 10(3):805-11. PubMed ID: 2195988
[TBL] [Abstract][Full Text] [Related]
8. In vitro antitumor activity of a new platinum complex, cis-malonato [(4R,5R)-4,5-bis(aminomethyl)-2-isopropyl-1,3-dioxolane] platinum (II) (SKI 2053R), against human lung and stomach cancer cell lines.
Hong WS; Kim HT; Kim KH; Kim DK
Anticancer Res; 1995; 15(1):51-4. PubMed ID: 7733640
[TBL] [Abstract][Full Text] [Related]
9. [Experimental study on combination chemotherapy with platinum compounds and 5-fluorouracil].
Furukawa S; Yoshida T; Tukuda M; Yanoma S; Ryo I; Miyata K; Kubota A; Mochimatsu I; Sawaki S
Gan To Kagaku Ryoho; 1989 Mar; 16(3 Pt 1):419-22. PubMed ID: 2649008
[No Abstract] [Full Text] [Related]
10. Antitumor activity of satraplatin in cisplatin-resistant oral squamous cell carcinoma cells.
Yamano Y; Shiiba M; Negoro K; Nakatani K; Kasamatsu A; Yamatoji M; Sakuma K; Ogoshi K; Iyoda M; Shinozuka K; Yokoe H; Wada T; Fujita S; Iwasawa S; Takiguchi Y; Tanzawa H; Uzawa K
Head Neck; 2011 Mar; 33(3):309-17. PubMed ID: 20848452
[TBL] [Abstract][Full Text] [Related]
11. [The lethal and kinetic effects of carboplatin studied using the human tumor clonogenic assay and flow cytometry].
Fujikane T; Tsuji T; Shimizu T; Onodera S
Nihon Gan Chiryo Gakkai Shi; 1988 Jul; 23(7):1525-37. PubMed ID: 3053943
[No Abstract] [Full Text] [Related]
12. Oxaliplatin induces drug resistance more rapidly than cisplatin in H69 small cell lung cancer cells.
Stordal BK; Davey MW; Davey RA
Cancer Chemother Pharmacol; 2006 Aug; 58(2):256-65. PubMed ID: 16283310
[TBL] [Abstract][Full Text] [Related]
13. Murine leukemia L1210 cell lines with different patterns of resistance to platinum coordination complexes.
Eastman A; Illenye S
Cancer Treat Rep; 1984 Sep; 68(9):1189-90. PubMed ID: 6541096
[TBL] [Abstract][Full Text] [Related]
14. Anticancer activity of a series of platinum complexes integrating demethylcantharidin with isomers of 1,2-diaminocyclohexane.
Yu CW; Li KK; Pang SK; Au-Yeung SC; Ho YP
Bioorg Med Chem Lett; 2006 Mar; 16(6):1686-91. PubMed ID: 16386904
[TBL] [Abstract][Full Text] [Related]
15. [Experimental study on the anti-tumor effect of CDDP derivatives against the gastric cancer cell lines].
Nitta A; Chung YS; Kato Y; Yashiro M; Maeda K; Kubo T; Nakata B; Okuno M; Sowa M
Gan To Kagaku Ryoho; 1994 Apr; 21(5):701-3. PubMed ID: 8154897
[No Abstract] [Full Text] [Related]
16. In vitro cytotoxicity, pharmacokinetics and ex vivo pharmacodynamics of a new platinum compound, cis-malonato [(4R,5R-4,5-bis(aminomethyl)-1,3-dioxolane-2-spiro-1'-cyclopentane] platinum (II).
Kim DK; Kim HT; Cho YB; Kim TS; Kim KH; Hong WS
Anticancer Res; 1996; 16(1):251-6. PubMed ID: 8615617
[TBL] [Abstract][Full Text] [Related]
17. Antitumor activity of platinum analogs against human lung cancer cell lines and tumor specimens.
Yonei T; Ohnoshi T; Hiraki S; Ueoka H; Kiura K; Moritaka T; Shibayama T; Tabata M; Segawa Y; Takigawa N
Acta Med Okayama; 1993 Aug; 47(4):233-41. PubMed ID: 8213217
[TBL] [Abstract][Full Text] [Related]
18. Antitumor activity of a new platinum(II) complex with low nephrotoxicity and genotoxicity.
Marzano C; Bettio F; Baccichetti F; Trevisan A; Giovagnini L; Fregona D
Chem Biol Interact; 2004 Jun; 148(1-2):37-48. PubMed ID: 15223355
[TBL] [Abstract][Full Text] [Related]
19. Activity of oxaliplatin against human tumor colony-forming units.
Raymond E; Lawrence R; Izbicka E; Faivre S; Von Hoff DD
Clin Cancer Res; 1998 Apr; 4(4):1021-9. PubMed ID: 9563898
[TBL] [Abstract][Full Text] [Related]
20. Differential nephrotoxicity of cisplatin and a novel series of traditional Chinese medicine-platinum anticancer agents correlates with their chemical reactivity towards sulfur-containing nucleophiles.
To KK; Au-Yeung SC; Ho YP
Anticancer Drugs; 2006 Jul; 17(6):673-83. PubMed ID: 16917213
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]